Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3lm4 | HPX | Catechol 2,3-dioxygenase |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3lm4 | HPX | Catechol 2,3-dioxygenase | / | 1.000 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.538 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.501 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.493 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.492 | |
| 1crb | RTL | Retinol-binding protein 1 | / | 0.490 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.489 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.488 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.486 | |
| 1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.485 | |
| 3djl | FAD | Putative acyl-CoA dehydrogenase AidB | 1.3.99 | 0.484 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.482 | |
| 2d06 | EST | Sulfotransferase 1A1 | 2.8.2.1 | 0.481 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.480 | |
| 3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.479 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.478 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.476 | |
| 1jlc | FTC | Gag-Pol polyprotein | 2.7.7.49 | 0.475 | |
| 2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.475 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.475 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.475 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.475 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.474 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.473 | |
| 3pn1 | IVH | DNA ligase | / | 0.472 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.472 | |
| 2wsa | 646 | Glycylpeptide N-tetradecanoyltransferase | / | 0.471 | |
| 3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.471 | |
| 3nxo | D2B | Dihydrofolate reductase | 1.5.1.3 | 0.471 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.471 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.471 | |
| 1xu9 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.470 | |
| 2a9z | 26A | Adenosine kinase | 2.7.1.20 | 0.470 | |
| 3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.470 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.470 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.470 | |
| 1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.469 | |
| 4rbs | 0RV | Metallo-beta-lactamase type 2 | / | 0.469 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.468 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.468 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.467 | |
| 4lsj | LSJ | Glucocorticoid receptor | / | 0.467 | |
| 3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
| 4bfy | ZVY | Pantothenate kinase | 2.7.1.33 | 0.466 | |
| 4iae | 1DX | Alr2278 protein | / | 0.466 | |
| 1olm | VTQ | SEC14-like protein 2 | / | 0.465 | |
| 2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
| 2zlc | VDX | Vitamin D3 receptor | / | 0.465 | |
| 3ha5 | SFG | Hydroxymycolate synthase MmaA4 | 2.1.1 | 0.465 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.465 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.465 | |
| 2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.464 | |
| 2zym | ACX | Periplasmic binding protein | / | 0.464 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.464 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.463 | |
| 1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.463 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.463 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.463 | |
| 4ea1 | 3RX | Dehydrosqualene synthase | / | 0.463 | |
| 1ohk | COP | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
| 2yjx | YJX | Heat shock protein HSP 90-alpha | / | 0.462 | |
| 3ix4 | TX1 | Transcriptional activator protein LasR | / | 0.462 | |
| 4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.462 | |
| 2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.461 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.461 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.461 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.461 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.461 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.460 | |
| 2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.460 | |
| 4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.460 | |
| 1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.459 | |
| 1l2j | ETC | Estrogen receptor beta | / | 0.459 | |
| 4at4 | T6E | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.459 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.459 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 3fnf | JPM | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
| 3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
| 5d7q | 4I5 | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.458 | |
| 1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.457 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.457 | |
| 1upw | 444 | Oxysterols receptor LXR-beta | / | 0.457 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.457 | |
| 3kpz | ZNE | Vitamin D3 receptor | / | 0.457 | |
| 4o7u | THF | Thymidylate synthase | / | 0.457 | |
| 4yau | FAD | NADPH--cytochrome P450 reductase | / | 0.457 | |
| 1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.456 | |
| 1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
| 1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.456 | |
| 2fwy | H64 | Heat shock protein HSP 90-alpha | / | 0.456 | |
| 3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.456 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.456 | |
| 3rl3 | 5GP | Metallophosphoesterase MPPED2 | 3.1 | 0.456 | |
| 4b1f | KRH | Glutamate racemase | / | 0.456 | |
| 4iah | 1DX | Alr2278 protein | / | 0.456 | |
| 4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.456 | |
| 4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.456 | |
| 2yhu | WHF | Pteridine reductase | / | 0.455 | |
| 2yk2 | YJX | Heat shock protein HSP 90-alpha | / | 0.455 | |
| 4awq | 592 | Heat shock protein HSP 90-alpha | / | 0.455 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.455 | |
| 5h8t | RTL | Retinol-binding protein 1 | / | 0.455 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
| 2c9z | QUE | Anthocyanidin 3-O-glucosyltransferase 2 | 2.4.1.115 | 0.454 | |
| 2hb8 | MVD | Vitamin D3 receptor | / | 0.454 | |
| 3o9l | LPN | Renin | 3.4.23.15 | 0.454 | |
| 3up3 | XCA | aceDAF-12 | / | 0.454 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 4jsg | Q10 | Nitric oxide synthase, brain | 1.14.13.39 | 0.454 | |
| 4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.454 | |
| 1frb | ZST | Aldose reductase-related protein 2 | / | 0.453 | |
| 1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.453 | |
| 2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.453 | |
| 3ch6 | 311 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.453 | |
| 3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.453 | |
| 3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
| 2ykc | YKC | Heat shock protein HSP 90-alpha | / | 0.452 | |
| 4hy6 | FJ1 | Heat shock protein HSP 90-alpha | / | 0.452 | |
| 2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.451 | |
| 2yxj | N3C | Bcl-2-like protein 1 | / | 0.451 | |
| 3bac | 3B9 | DNA ligase | / | 0.451 | |
| 4bvh | OCZ | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.451 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.451 | |
| 4uga | Q05 | Nitric oxide synthase oxygenase | 1.14.13.165 | 0.451 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.451 | |
| 1el4 | CTZ | Obelin | / | 0.450 | |
| 1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.450 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
| 2bfm | TOP | Pteridine reductase 1 | 1.5.1.33 | 0.450 | |
| 3fnh | JPJ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
| 3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.450 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.450 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.450 | |
| 1ddu | CB3 | Thymidylate synthase | / | 0.449 | |
| 1kqw | RTL | Cellular retinol-binding protein type II | / | 0.449 | |
| 1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.449 | |
| 2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.449 | |
| 2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.449 | |
| 2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.449 | |
| 3gie | ACP | Sensor histidine kinase DesK | 2.7.13.3 | 0.449 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.449 | |
| 4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.449 | |
| 1n4h | REA | Nuclear receptor ROR-beta | / | 0.448 | |
| 1s3w | TQT | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
| 2ykb | YKB | Heat shock protein HSP 90-alpha | / | 0.448 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
| 3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
| 4bfr | J82 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 2.7.1.153 | 0.448 | |
| 4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.448 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.448 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3sgy | 06W | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 4nie | NBH | Nuclear receptor ROR-gamma | / | 0.447 | |
| 5dp2 | NAP | CurF | / | 0.447 | |
| 1ie9 | VDX | Vitamin D3 receptor | / | 0.446 | |
| 1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.446 | |
| 1ysi | N3B | Bcl-2-like protein 1 | / | 0.446 | |
| 1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.446 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.446 | |
| 2gpv | OHT | Estrogen-related receptor gamma | / | 0.446 | |
| 2j5s | KTA | Alr4455 protein | / | 0.446 | |
| 2wks | CB6 | 3-dehydroquinate dehydratase | 4.2.1.10 | 0.446 | |
| 2yke | YKE | Heat shock protein HSP 90-alpha | / | 0.446 | |
| 3hf8 | ML0 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.446 | |
| 3hxb | BD5 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.446 | |
| 3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.446 | |
| 4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.446 | |
| 4c3y | ANB | 3-ketosteroid dehydrogenase | / | 0.446 | |
| 4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.446 | |
| 4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.446 | |
| 4qzu | RTL | Retinol-binding protein 2 | / | 0.446 | |
| 5jsc | FAD | Putative acyl-CoA dehydrogenase | / | 0.446 | |
| 1kia | SAM | Glycine N-methyltransferase | 2.1.1.20 | 0.445 | |
| 1sjw | NGV | Nogalonic acid methyl ester cyclase | / | 0.445 | |
| 1x8l | OXR | Retinol dehydratase | / | 0.445 | |
| 2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 3c14 | FOK | Adenylate cyclase type 2 | / | 0.445 | |
| 3c14 | FOK | Adenylate cyclase type 5 | / | 0.445 | |
| 3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
| 3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.445 | |
| 3n5w | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.445 | |
| 3nxt | D2E | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
| 4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.445 | |
| 4jvn | YUG | Estrogen sulfotransferase | 2.8.2.4 | 0.445 | |
| 4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
| 4xoq | F42 | Coenzyme F420:L-glutamate ligase | / | 0.445 | |
| 1uyf | PU1 | Heat shock protein HSP 90-alpha | / | 0.444 | |
| 1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 2fpc | SCG | Strictosidine synthase | 4.3.3.2 | 0.444 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.444 | |
| 3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.444 | |
| 4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.444 | |
| 4gn6 | TYL | Lactoperoxidase | 1.11.1.7 | 0.444 | |
| 4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 4n1f | CZH | Obelin | / | 0.444 | |
| 1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.443 | |
| 1uyk | PUX | Heat shock protein HSP 90-alpha | / | 0.443 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 2jfa | RAL | Estrogen receptor | / | 0.443 | |
| 2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 2zat | NAP | Dehydrogenase/reductase SDR family member 4 | 1.1.1.184 | 0.443 | |
| 3d4b | DZD | NAD-dependent protein deacetylase | / | 0.443 | |
| 3dqr | JI2 | Nitric oxide synthase, brain | 1.14.13.39 | 0.443 | |
| 3fzn | D7K | Benzoylformate decarboxylase | 4.1.1.7 | 0.443 | |
| 3gki | CLR | Niemann-Pick C1 protein | / | 0.443 | |
| 3nxv | D2F | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.443 | |
| 4mt9 | 2D6 | Tankyrase-1 | 2.4.2.30 | 0.443 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.443 | |
| 1bzf | TMQ | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 1mrq | STR | Aldo-keto reductase family 1 member C1 | / | 0.442 | |
| 1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
| 1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
| 2hx4 | 4HX | Nitric oxide synthase, brain | 1.14.13.39 | 0.442 | |
| 2p7z | OHT | Estrogen-related receptor gamma | / | 0.442 | |
| 2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.442 | |
| 3iel | U5P | Ribonuclease TTHA0252 | 3.1 | 0.442 | |
| 3qkd | HI0 | Bcl-2-like protein 1 | / | 0.442 | |
| 3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.442 | |
| 4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.442 | |
| 4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.442 | |
| 1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 1fdt | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.441 | |
| 1fml | RTL | Retinol dehydratase | / | 0.441 | |
| 1gal | FAD | Glucose oxidase | 1.1.3.4 | 0.441 | |
| 1o6r | R19 | Squalene--hopene cyclase | 4.2.1.129 | 0.441 | |
| 1pd8 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 1uyd | PU8 | Heat shock protein HSP 90-alpha | / | 0.441 | |
| 2p1t | 3TN | Retinoic acid receptor RXR-alpha | / | 0.441 | |
| 3dge | ADP | Sensor histidine kinase | / | 0.441 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.441 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.441 | |
| 3qv1 | NAD | Glyceraldehyde-3-phosphate dehydrogenase GAPA1, chloroplastic | 1.2.1.13 | 0.441 | |
| 3sso | SAH | Mycinamicin VI 2''-O-methyltransferase | / | 0.441 | |
| 3w0u | HPW | Lactoylglutathione lyase | 4.4.1.5 | 0.441 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.441 | |
| 4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 4iji | 99T | Glutathione S-transferase-like protein YibF | / | 0.441 | |
| 4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.441 | |
| 1cf3 | FAD | Glucose oxidase | 1.1.3.4 | 0.440 | |
| 1fp1 | HCC | Isoliquiritigenin 2'-O-methyltransferase | / | 0.440 | |
| 1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 1p33 | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.440 | |
| 1s64 | 778 | Geranylgeranyl transferase type-1 subunit beta | 2.5.1.59 | 0.440 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.440 | |
| 1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
| 2a9y | 26A | Adenosine kinase | 2.7.1.20 | 0.440 | |
| 2b35 | TCL | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3h3q | H13 | Collagen type IV alpha-3-binding protein | / | 0.440 | |
| 3lak | KR1 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
| 3p9t | TCL | Repressor | / | 0.440 | |
| 3qi4 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
| 3w0j | T08 | Vitamin D3 receptor | / | 0.440 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.440 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.440 | |
| 4lux | QJ8 | Nitric oxide synthase, brain | 1.14.13.39 | 0.440 | |
| 4xrg | NAD | Homospermidine synthase | 2.5.1.44 | 0.440 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.440 |